Election mascots are meant to spread SVEEP awareness, from Chennai’s “Namma Thanga”, a blue cartoon crow, to Coimbatore’s “Therthal Veeran”, a hornbill. In Virudhunagar, however, the choice of a ...

Like many pillars of our world, Cartoon Network is not the same as it used to be, fast eroding along with other family-oriented cable TV channels under the pressures of late capitalist, post-pandemic, ...

Tubi is in its "cartoon era." In a Feb. 13 post on X, the free on-demand streaming service revealed it was adding 100 animated shows to its platform beginning March 1. Founded in 2014, Tubi offers ...

(RTTNews) - Vir Biotechnology, Inc. (VIR), a clinical-stage biopharmaceutical company, Thursday announced the pricing of 17.65 million shares at a price of $8.50 per share. The gross proceeds are ...

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.76 per share a year ago. These ...

Vir signed a “landmark” collaboration with Astellas to advance VIR-5500, receiving $315 million upfront ( $240M cash + $75M equity) and becoming eligible for up to $1.37 billion in milestones, with a ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Shares for Vir Biotechnology climbed by nearly 30% ...

VIR-5500 pairs PSMA targeting with CD3 engagement and PRO-XTEN masking intended to limit systemic T-cell activation until tumor-localized unmasking, potentially reducing off-tumor toxicity. Metastatic ...

Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 ...

Forbes contributors publish independent expert analyses and insights. Sabrina Reed is a journalist who covers Hollywood and the TV industry. Since Warner Bros. Discovery closed Cartoon Network’s ...

Amanda M. Castro is a Network TV writer at Collider and a New York–based journalist whose work has appeared in Newsweek, where she contributes as a Live Blog Editor, and The U.S. Sun, where she ...

Good afternoon, everyone. My name is Mary Liu, and I'm one of the associates on the healthcare investment banking team at JPMorgan. It's my pleasure to introduce our next presentation from Vir ...